yxfbbiedtj
ORANGE EKSTRAKLASA
Dołączył: 03 Mar 2011
Posty: 720
Przeczytał: 0 tematów
Ostrzeżeń: 0/5
Skąd: England
|
 Wysłany: Nie 9:58, 20 Mar 2011 |
|
|
Etodolac bioequivalence of tablets
indsofetodolacpreparationsafterasingleoral offering coverage similar to tl 『 2 7.45h . In addition,[link widoczny dla zalogowanych], the test and control drug of dose400mgin20healthyvolunteers between ln (AI 『 c) and ln (AI 『 c) have a difference between individuals (P.05). ParametersTestControl bundle of sweet white Wang II field F :, 00RO +,[link widoczny dla zalogowanych],) n,[link widoczny dla zalogowanych], 0 / right- a chuan left Rno / ~ (m34.107 '5229 · 846'42125% ,[link widoczny dla zalogowanych], but maybe slightly different due to experimental conditions before and after the result . The double- Single 113039. (h). ± .1.63 ± 0.76 ... ... ... ... ... ... ... ... ...... ... ... ... a f (h) 8.18 ± 1.938.66 ± 1.08 side f test and calculation AUCo ship , AUCo I and the C, 90% n-H Range, can prove that two formulations are students AUC0-(mg · h · L a ) 184.76 ± 48.75190.23 ± 58.95 material equivalent preparations . F (%) 99.89 ± 20.4420名Health love again in the test period were not aware of any drug is not (mean ± SD, n = 20) adverse reactions , the subjects tolerated ,[link widoczny dla zalogowanych], and no complaints were , that the drug bioequivalence study in 3 clinical use Safer . the two formulations of the AUC., AUC and the logarithm of the measured cm
Post został pochwalony 0 razy
|
|
